Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Tanoto Foundation Collaborates with Asia Philanthropy Circle on Groundbreaking Study on Early Childhood Development across Asia
Media-OutReach Newswire DHL Express helps global law firm Linklaters cut carbon emissions using sustainable aviation fuel
Opinion Target programme for ethnic minority requires active engagement from all stakeholders: Minister